AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
An elderly Oklahoma woman stricken with Parkinson’s Disease lost $20,000 in a cryptocurrency ploy that was crafted as a scam ...
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
to develop exercise equipment for Parkinson’s Disease patients in the area. One result of Hunter’s efforts includes a machine ...
A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...
AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an ...
GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...
Nottinghamshire Live on MSN8h
Nightmares could be a symptom of serious illnesses like Parkinson's or heart problemsNightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...
Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback